Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PBL Assay Science, formerly known as PBL Biomedical Laboratories, is a specialized life sciences company that provides high-quality products and services for cytokine and interferon research. Founded in 1990 by Dr. Sidney Pestka, a pioneer in interferon research, the company is a global leader in the production of interferon proteins, antibodies, and highly sensitive ELISA kits. In January 2024, the company was acquired by Sino Biological, a leading provider of biological research reagents and services, to expand its presence in the cytokine detection market. Beyond its extensive product catalog, PBL offers contract research services, including biomarker analysis and assay development, for pharmaceutical and academic clients. The company's expertise supports critical research in immunology, oncology, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PBLbiolab.